Literature DB >> 16836494

An epidemiology study of patients with uremic pruritus.

S Mistik1, S Utas, A Ferahbas, B Tokgoz, G Unsal, H Sahan, A Ozturk, C Utas.   

Abstract

BACKGROUND: Pruritus is a common problem in continuous ambulatory peritoneal dialysis (CAPD) and haemodialysis patients. There are few studies on the clinical characteristics of uremic itch, the cause of which is still unknown.
OBJECTIVES: The aim of this study was to define the prevalence and clinical characteristics of pruritus in CAPD and haemodialysis patients.
METHODS: A questionnaire was used to evaluate pruritus in 52 CAPD and 289 haemodialysis patients in two dialysis units. The relationship of various factors and medical parameters to itch was examined.
RESULTS: Of the 341 patients, 177 (51.9%) had pruritus at the time of examination, 97 (28.4%) had pruritus in the past. Pruritus was present in 145 (50.2%) of the haemodialysis patients and 32 (61.5%) of the CAPD patients. Men, patients with liver disease, and patients with pruritus before starting dialysis treatment were more likely to have uremic pruritus.
CONCLUSIONS: This study showed us that uremic pruritus was observed more in men than women. The high prevalence of uremic pruritus in our study does not support the decrease of pruritus due to an improvement in the management of dialysis patients.

Entities:  

Mesh:

Year:  2006        PMID: 16836494     DOI: 10.1111/j.1468-3083.2006.01570.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  28 in total

1.  Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care.

Authors:  Sara N Davison; Adeera Levin; Alvin H Moss; Vivekanand Jha; Edwina A Brown; Frank Brennan; Fliss E M Murtagh; Saraladevi Naicker; Michael J Germain; Donal J O'Donoghue; Rachael L Morton; Gregorio T Obrador
Journal:  Kidney Int       Date:  2015-04-29       Impact factor: 10.612

Review 2.  Pruritus in Kidney Disease.

Authors:  Sara A Combs; J Pedro Teixeira; Michael J Germain
Journal:  Semin Nephrol       Date:  2015-07       Impact factor: 5.299

Review 3.  Therapeutic Effects of Omega-3 Fatty Acids on Chronic Kidney Disease-Associated Pruritus: a Literature Review.

Authors:  Yunes Panahi; Simin Dashti-Khavidaki; Farahnoosh Farnood; Hamid Noshad; Mahsa Lotfi; Afshin Gharekhani
Journal:  Adv Pharm Bull       Date:  2016-12-22

4.  Epidermal Proteinase-Activated Receptor-2 Expression is Increased in End-Stage Renal Disease Patients with Pruritus: A Pilot Study.

Authors:  Sung Jin Moon; Hyun Jung Kim; Sung Bin Cho; Seung Hun Lee; Hoon Young Choi; Hyeong Cheon Park; Sung Kyu Ha
Journal:  Electrolyte Blood Press       Date:  2014-12-31

Review 5.  Uraemic pruritus: clinical characteristics, pathophysiology and treatment.

Authors:  Lucio Manenti; Pius Tansinda; Augusto Vaglio
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 6.  [Pruritus and dryness of the skin in chronic kidney insufficiency and dialysis patients - a review].

Authors:  Ulrike Durrant-Finn; Bernd Osten; Claudia Mügge; Pietro Nenoff
Journal:  Wien Med Wochenschr       Date:  2009

7.  Advanced aging skin and itch: addressing an unmet need.

Authors:  Lilit Garibyan; Albert S Chiou; Sarina B Elmariah
Journal:  Dermatol Ther       Date:  2013 Mar-Apr       Impact factor: 2.851

Review 8.  Skin problems in chronic kidney disease.

Authors:  Dirk R J Kuypers
Journal:  Nat Clin Pract Nephrol       Date:  2009-02-03

Review 9.  Cutaneous manifestations of ESRD.

Authors:  Timur A Galperin; Antonia J Cronin; Kieron S Leslie
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 8.237

10.  Evaluation of the causes affecting the development of pruritus in patients with peritoneal dialysis.

Authors:  Sumeyra Koyuncu; Eda Oksum Solak; Cigdem Karakukcu; Ali Gundogdu; Cihan Uysal; Gökmen Zararsız; Ismail Kocyigit; Murat Hayri Sipahioğlu; Oktay Oymak; Murat Borlu; Bulent Tokgoz
Journal:  Int Urol Nephrol       Date:  2021-07-02       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.